Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adeno-associated vector corneal gene therapy reverses corneal clouding in a feline model of mucopolysaccharidosis VI.

PloS one·2025
Same author

Cardiotropic AAV gene therapy for heart failure: a phase 1 trial.

Nature medicine·2025
Same author

New hope for older SMA patients with next-generation self-complementary AAV gene therapy.

Molecular therapy : the journal of the American Society of Gene Therapy·2025
Same author

AAV vector transduction restriction and attenuated toxicity in hESCs via a rationally designed inverted terminal repeat.

Nucleic acids research·2025
Same author

Protective role of RIPK1 scaffolding against HDV-induced hepatocyte cell death and the significance of cytokines in mice.

PLoS pathogens·2024
Same author

Chemical Epigenetic Regulation of Adeno-Associated Virus Delivered Transgenes.

Human gene therapy·2023

Related Experiment Video

Updated: May 16, 2025

Process Development for the Production and Purification of Adeno-Associated Virus AAV2 Vector using Baculovirus-Insect Cell Culture System
10:31

Process Development for the Production and Purification of Adeno-Associated Virus AAV2 Vector using Baculovirus-Insect Cell Culture System

Published on: January 13, 2022

9.1K

AAV vector development, back to the future.

Lester Suarez-Amaran1, Liujiang Song2, Anna P Tretiakova2

  • 1M34, Inc., 870 Martin Luther King Jr. Boulevard, Chapel Hill, NC 27514-2600, USA; Orthopaedic Research Center, C. Wayne McIlwraith Translational Medicine Institute, College of Veterinary Medicine, Colorado State University, Fort Collins, CO 80523, USA.

Molecular Therapy : the Journal of the American Society of Gene Therapy
|April 5, 2025
PubMed
Summary
This summary is machine-generated.

Adeno-associated virus (AAV) vectors are crucial for gene therapy, enabling long-term gene expression. Recent advancements, including in vivo evolution in human decedents, are refining AAV for enhanced therapeutic applications.

Keywords:
AAVAAV libraryITRdirected evolutiongene therapyhuman decedentrational designviral vectors

More Related Videos

Production, Purification, and Quality Control for Adeno-associated Virus-based Vectors
09:21

Production, Purification, and Quality Control for Adeno-associated Virus-based Vectors

Published on: January 29, 2019

35.8K
Author Spotlight: Improved Method for Production and Purification of Adeno-Associated Viral Vectors
09:12

Author Spotlight: Improved Method for Production and Purification of Adeno-Associated Viral Vectors

Published on: April 5, 2024

2.7K

Related Experiment Videos

Last Updated: May 16, 2025

Process Development for the Production and Purification of Adeno-Associated Virus AAV2 Vector using Baculovirus-Insect Cell Culture System
10:31

Process Development for the Production and Purification of Adeno-Associated Virus AAV2 Vector using Baculovirus-Insect Cell Culture System

Published on: January 13, 2022

9.1K
Production, Purification, and Quality Control for Adeno-associated Virus-based Vectors
09:21

Production, Purification, and Quality Control for Adeno-associated Virus-based Vectors

Published on: January 29, 2019

35.8K
Author Spotlight: Improved Method for Production and Purification of Adeno-Associated Viral Vectors
09:12

Author Spotlight: Improved Method for Production and Purification of Adeno-Associated Viral Vectors

Published on: April 5, 2024

2.7K

Area of Science:

  • Molecular Biology
  • Gene Therapy
  • Virology

Background:

  • Adeno-associated virus (AAV) is a key vector for gene therapy, facilitating sustained transgene expression.
  • Its journey from a contaminant to a clinical tool highlights significant scientific progress.
  • AAV's versatility is crucial for treating various genetic disorders.

Purpose of the Study:

  • To provide a comprehensive review of AAV's historical development and molecular evolution.
  • To examine advancements in AAV vector engineering, genome regulation, and clinical applications.
  • To highlight novel AAV selection strategies using human decedent administration.

Main Methods:

  • Review of historical AAV research and clinical trial data.
  • Analysis of molecular evolution techniques including rational design and directed evolution.
  • Exploration of AAV genome regulation, focusing on ITRs and capsid-genome interactions.
  • Assessment of in vivo AAV library selection in human decedents.

Main Results:

  • AAV vector engineering has significantly expanded therapeutic potential across diverse diseases.
  • Understanding of AAV genome regulation, particularly ITRs, is critical for transduction efficiency.
  • Successful in vivo selection of AAV libraries in human decedents marks a novel evolutionary milestone.
  • Current and past clinical trials demonstrate AAV's growing impact in gene therapy.

Conclusions:

  • AAV vector optimization is accelerating the development of next-generation gene therapies.
  • Enhanced clinical translatability of AAV vectors promises to revolutionize gene therapy.
  • Future research directions focus on refining AAV for broader and more effective therapeutic use.